A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors-Reference-Cited by-同舟云学术

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors

Published:2017-11-14 Issue:4 Volume:24 Page:744-752
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Wahner Hendrickson Andrea E.,Menefee Michael E.,Hartmann Lynn C.,Long Harry J.,Northfelt Donald W.,Reid Joel M.,Boakye-Agyeman Felix,Kayode Olumide,Flatten Karen S.,Harrell Maria I.,Swisher Elizabeth M.,Poirer Guy G.,Satele Daniel,Allred Jake,Lensing Janet L.,Chen Alice,Ji Jiuping,Zang Yiping,Erlichman Charles,Haluska Paul,Kaufmann Scott H.

Funder

National Cancer Institute

Ovarian Cancer Research Fund Alliance—National Ovarian Cancer Coalition Dream Team Translational Research Grant

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Veliparib exerts protective effects in intracerebral hemorrhage mice by inhibiting the inflammatory response and accelerating hematoma resolution;Brain Research;2024-09

2. PARP1-dependent DNA-protein crosslink repair;Nature Communications;2024-08-05

3. Quantification of Unencapsulated Drug in Target Tissues Demonstrates Pharmacological Properties and Therapeutic Effects of Liposomal Topotecan (FF-10850);Pharmaceutical Research;2024-03-27

4. Pyrazinamide Analogs Designed for Rational Drug Designing Strategies Against Resistant Tuberculosis (A Review);Russian Journal of Bioorganic Chemistry;2024-02

5. FF-10850, a Novel Liposomal Topotecan Achieves Superior Antitumor Activity via Macrophage- and Ammonia-Mediated Payload Release in the Tumor Microenvironment;Molecular Cancer Therapeutics;2023-09-08